Alvocidib

From WikiMD.org
Jump to navigation Jump to search

Alvocidib (pronounced al-vo-si-dib) is a synthetic flavonoid derivative that is used in medical research, particularly in the field of oncology. It is a potent inhibitor of cyclin-dependent kinases (CDKs), which are enzymes that play a crucial role in cell cycle regulation.

Etymology

The term "Alvocidib" is derived from the Latin words "alvo" meaning "white" and "cidib" meaning "to kill". This is in reference to its potential use as a cancer-killing agent.

Usage

Alvocidib is primarily used in preclinical and clinical trials as a potential treatment for various types of cancer. It works by inhibiting the activity of CDKs, thereby preventing the uncontrolled cell division that characterizes cancer.

Related Terms

  • Flavonoid: A diverse group of plant metabolites thought to provide health benefits through cell signalling pathways and antioxidant effects.
  • Cyclin-dependent kinases (CDKs): A family of protein kinases first discovered for their role in regulating the cell cycle.
  • Oncology: A branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski